SCHEMBL22553908

SCHEMBL22553908

Cn1cc(-c2cncc(-c3ccc(N4CCCC4=O)cc3)c2)c2cc(N3CCNCC3)cnc21

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 1/20 0.42
TGFBR1 P36897 7/20 0.42
ACVR1 Q04771 8/20 0.41
ACVR1B P36896 1/20 0.41
BRD4 O60885 1/20 0.40
BRDT Q58F21 1/20 0.40
CCNC P24863 1/20 0.40
CDK8 P49336 1/20 0.40
PIP4K2A P48426 1/20 0.39
ACVRL1 P37023 4/20 0.38
BMPR1B O00238 3/20 0.38
BMPR1A P36894 3/20 0.38
CHEK1 O14757 1/20 0.36
RIPK2 O43353 1/20 0.36
CCND1 P24385 1/20 0.36
CDK6 Q00534 1/20 0.36
SYK P43405 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22554063 0.91 BRD4 (0.45) BRD4BRDTCCNCCDK8PIP4K2A
SCHEMBL22578454 0.87 CHEK1 (0.43) BRD4BRDTCCNCCDK8PIP4K2A
SCHEMBL22553891 0.83 BRD4 (0.44) BRD4BRDTCCNCCDK8PIP4K2A
SCHEMBL30730819 0.83 BRD4 (0.43) BRD4BRDTCCNCCDK8PIP4K2A
SCHEMBL22554125 0.83 BRD4 (0.43) BRD4BRDTCCNCCDK8PIP4K2A
SCHEMBL22553729 0.83 BRD4 (0.43) BRD4BRDTCCNCCDK8PIP4K2A
SCHEMBL22554159 0.82 BRD4 (0.40) BRD4BRDTCCNCCDK8PIP4K2A
SCHEMBL22553919 0.82 PIP4K2A (0.46) BRD4BRDTCCNCCDK8PIP4K2A
SCHEMBL22553754 0.82 BRD4 (0.49) BRD4BRDTCCNCCDK8PIP4K2A
SCHEMBL30730836 0.82 PIP4K2A (0.46) BRD4BRDTCCNCCDK8PIP4K2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11919902-B2 Aryl-bipyridine amine derivatives as phosphatidylinositol phosphate kinase inhibitors HIBERCELL, INC. (US) 2024-03-05 US claimed
EP-3728230-A1 ARYL-BIPYRIDINE AMINE DERIVATIVES AS PHOSPHATIDYLINOSITOL PHOSPHATE KINASE INHIBITORS Ravenna Pharmaceuticals, Inc. (US) 2020-10-28 EP claimed
US-20200331913-A1 ARYL-BIPYRIDINE AMINE DERIVATIVES AS PHOSPHATIDYLINOSITOL PHOSPHATE KINASE INHIBITORS HIBERCELL, INC. 2020-10-22 US claimed
US-11919902-B2 Aryl-bipyridine amine derivatives as phosphatidylinositol phosphate kinase inhibitors HIBERCELL, INC. (US) 2024-03-05 US disclosed
EP-3728230-A1 ARYL-BIPYRIDINE AMINE DERIVATIVES AS PHOSPHATIDYLINOSITOL PHOSPHATE KINASE INHIBITORS Ravenna Pharmaceuticals, Inc. (US) 2020-10-28 EP disclosed
US-20200331913-A1 ARYL-BIPYRIDINE AMINE DERIVATIVES AS PHOSPHATIDYLINOSITOL PHOSPHATE KINASE INHIBITORS HIBERCELL, INC. 2020-10-22 US disclosed
US-20200331913-A1 ARYL-BIPYRIDINE AMINE DERIVATIVES AS PHOSPHATIDYLINOSITOL PHOSPHATE KINASE INHIBITORS HIBERCELL, INC. 2020-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200331913-A1 ARYL-BIPYRIDINE AMINE DERIVATIVES AS PHOSPHATIDYLINOSITOL PHOSPHATE KINASE INHIBITORS PIP5K1A, PIP5K1B, PIP5K1C HTR6 2181/4885TGFBR1 3028/4885ACVR1 3809/4885
US-11919902-B2 Aryl-bipyridine amine derivatives as phosphatidylinositol phosphate kinase inhibitors PIP5K1A, PIP5K1B, PIP5K1C HTR6 2181/4885TGFBR1 3028/4885ACVR1 3809/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.